Literature DB >> 7115877

The two-period changeover design in clinical trials.

A P Grieve.   

Abstract

Mesh：

Year:  1982        PMID： 7115877

Source DB:  PubMed          Journal:  Biometrics        ISSN： 0006-341X            Impact factor:   2.571


× No keyword cloud information.
  8 in total

1.  Spline functions in convolutional modeling of verapamil bioavailability and bioequivalence. II: study in healthy volunteers.

Authors:  J Popović; R Mitić; A Sabo; M Mikov; V Jakovljević; K Daković-Svajcer
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2006 Apr-Jun       Impact factor: 2.441

Review 2.  Review of methods and criteria for the evaluation of bioequivalence studies.

Authors:  G Pabst; H Jaeger
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

3.  Statistical analysis of bioavailability studies: parametric and nonparametric confidence intervals.

Authors:  V W Steinijans; E Diletti
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

4.  The influence of food on the pharmacokinetics of CGP 6140 (amocarzine) after oral administration of a 1200 mg single dose to patients with onchocerciasis.

Authors:  J B Lecaillon; J P Dubois; G Soula; E Pichard; A A Poltera; C D Ginger
Journal:  Br J Clin Pharmacol       Date:  1990-10       Impact factor: 4.335

5.  Efficacy and safety of insulin glargine 300 U/mL vs insulin degludec in patients with type 2 diabetes: A randomized, open-label, cross-over study using continuous glucose monitoring profiles.

Authors:  Yuji Kawaguchi; Jun Sawa; Noriko Sakuma; Yasuro Kumeda
Journal:  J Diabetes Investig       Date:  2018-07-28       Impact factor: 4.232

6.  Effects of a remote patient monitoring system for patients on automated peritoneal dialysis: a randomized crossover controlled trial.

Authors:  Kiyotaka Uchiyama; Kohkichi Morimoto; Naoki Washida; Ei Kusahana; Takashin Nakayama; Tomoaki Itoh; Takahiro Kasai; Shu Wakino; Hiroshi Itoh
Journal:  Int Urol Nephrol       Date:  2022-04-01       Impact factor: 2.266

7.  Efficacy of IDegLira Versus IDegAsp Therapy in Patients with Type 2 Diabetes: A Randomized Crossover Study by isCGM.

Authors:  Yuji Kawaguchi; Shoko Miyamoto; Yuriko Hajika; Narumi Ashida; Tomoe Hirota; Koji Masumoto; Jun Sawa; Kenji Hamazaki; Yasuro Kumeda
Journal:  Adv Ther       Date:  2022-04-11       Impact factor: 4.070

8.  The design and analysis of vaccine trials for COVID-19 for the purpose of estimating efficacy.

Authors:  Stephen Senn
Journal:  Pharm Stat       Date:  2022-07       Impact factor: 1.234
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.